Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: My recommendation in case of the futur PTSC strategy to the BOD/CEO:

No Dividends. Just a waste of good money. CASH is KING hold all the money you can for acquisition (s). That is right thing to do.

Share
New Message
Please login to post a reply